Advance misoprostol distribution for preventing and treating postpartum haemorrhage.

BACKGROUND Advance community distribution of misoprostol for preventing or treating postpartum haemorrhage (PPH) has become an attractive strategy to expand uterotonic coverage to places where conventional uterotonic use is not feasible. However, the value and safety of this strategy remain contentious. OBJECTIVES To assess the effectiveness and safety of a strategy of advance misoprostol distribution for PPH prevention and treatment in non-facility births. SEARCH METHODS We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (5 October 2011). We did not apply any language restrictions. SELECTION CRITERIA Randomised or quasi-randomised controlled trials of advance misoprostol distribution to lay health workers or pregnant women compared with usual care for PPH prevention or treatment in non-facility births. We excluded studies without any form of random design. DATA COLLECTION AND ANALYSIS Two review authors independently assessed trial eligibility for inclusion. MAIN RESULTS The search strategies identified three studies. None of the studies met the inclusion criteria. AUTHORS' CONCLUSIONS There is no evidence from randomised or quasi-randomised trials on the benefits or risks of a strategy of advance misoprostol distribution for PPH prevention or treatment in non-facility births. In view of the increasing interest to scale up this strategy, there is an urgent need for large and well-designed randomised trials to evaluate its comparative benefits and risks.

[1]  J. Gondry,et al.  [Role of misoprostol in the delivery outcome]. , 2001, Journal de gynecologie, obstetrique et biologie de la reproduction.

[2]  M. Potts,et al.  Prevention of postpartum hemorrhage: options for home births in rural Ethiopia. , 2009, African journal of reproductive health.

[3]  A Metin Gülmezoglu,et al.  WHO analysis of causes of maternal death: a systematic review , 2006, The Lancet.

[4]  G. Mbaruku,et al.  Using the kanga to measure postpartum blood loss , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[5]  J. Hatcher,et al.  Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial , 2010, BJOG : an international journal of obstetrics and gynaecology.

[6]  S. Goudar,et al.  Conducting International Collaborative Research in Developing Nations , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[7]  J. Anthony.  Managing Complications in Pregnancy and Childbirth. A Guide for Midwives and Doctors , 2008 .

[8]  Cemach.  Saving mothers' lives: reviewing maternal deaths to make motherhood safer - 2003-2005 , 2007 .

[9]  J. Higgins,et al.  Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration , 2013 .

[10]  S. Goudar,et al.  The efficacy of oral misoprostol in preventing postpartum hemorrhage in a community setting: A randomized double‐blind placebo‐controlled trial , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[11]  S. Goudar,et al.  Initiating a novel therapy in preventing postpartum hemorrhage in rural India: a joint collaboration between the United States and India. , 2004, International journal of fertility and women's medicine.

[12]  H. Gordon,et al.  Reaction to blood loss at delivery , 1990 .

[13]  G. Hofmeyr,et al.  Prostaglandins for preventing postpartum haemorrhage. , 2012, The Cochrane database of systematic reviews.

[14]  G. Justus Hofmeyr,et al.  A randomised placebo controlled trial of oral misoprostol in the third stage of labour , 1998, British journal of obstetrics and gynaecology.

[15]  D. Selo-Ojeme.  Primary postpartum haemorrhage , 2002, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[16]  O. Campbell,et al.  A population-based surveillance study on severe acute maternal morbidity (near-miss) and adverse perinatal outcomes in Campinas, Brazil: The Vigimoma Project , 2011, BMC pregnancy and childbirth.

[17]  D. Chestnut.  Postpartum hemorrhage – update on problems of definitions and diagnosis , 2012 .

[18]  M. Potts,et al.  Maternal mortality: one death every 7 min , 2010, The Lancet.

[19]  B. S. Dhillon,et al.  Oral misoprostol for prevention of postpartum hemorrhage by paramedical workers in India , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[20]  F. Vahidnia,et al.  Controlling postpartum hemorrhage after home births in Tanzania , 2005, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[21]  A. Costello,et al.  Reducing maternal and neonatal mortality in the poorest communities , 2004, BMJ : British Medical Journal.

[22]  P. Doyle,et al.  Risk factors for severe post partum haemorrhage in Mulago hospital, Kampala, Uganda. , 2008, East African medical journal.

[23]  H. Chakraborty,et al.  Variation in the postpartum hemorrhage rate in a clinical trial of oral misoprostol , 2008, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[24]  C. Stanton,et al.  How to avoid iatrogenic morbidity and mortality while increasing availability of oxytocin and misoprostol for PPH prevention? , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[25]  Z. Alfirevic,et al.  Prevention of postpartum hemorrhage with misoprostol , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[26]  N. K. Sharma,et al.  Maternal mortality ratio and predictors of maternal deaths in selected desert districts in rajasthan a community-based survey and case control study. , 2010, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[27]  Carol Bellamy,et al.  'The state of the world's children'. , 1985, People Count.

[28]  Edgardo Abalos,et al.  Epidemiology of postpartum haemorrhage: a systematic review. , 2008, Best practice & research. Clinical obstetrics & gynaecology.

[29]  V. Tsu,et al.  Postpartum hemorrhage in developing countries: is the public health community using the right tools? , 2004, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[30]  P. Aaby,et al.  Effect of sublingual misoprostol on severe postpartum haemorrhage in a primary health centre in Guinea-Bissau: randomised double blind clinical trial , 2005, BMJ : British Medical Journal.

[31]  H. Chakraborty,et al.  Side effects of oral misoprostol for the prevention of postpartum hemorrhage: Results of a community-based randomised controlled trial in rural India , 2009, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[32]  H. Gibson,et al.  AVERTING MATERNAL DEATH AND DISABILITY Prevention of postpartum hemorrhage at home birth in Afghanistan , 2009 .

[33]  Z. Alfirevic,et al.  Major postpartum hemorrhage: survey of maternity units in the United Kingdom , 2002 .

[34]  J. Neilson,et al.  Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006–2008 , 2011, BJOG : an international journal of obstetrics and gynaecology.

[35]  H. Chakraborty,et al.  Oral misoprostol in preventing postpartum haemorrhage in resource-poor communities: a randomised controlled trial , 2006, The Lancet.

[36]  P J Kelly,et al.  Postpartum hemorrhage in resource‐poor settings , 2006, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[37]  T. Colbourn,et al.  Estimation of potential effects of improved community-based drug provision, to augment health-facility strengthening, on maternal mortality due to post-partum haemorrhage and sepsis in sub-Saharan Africa: an equity-effectiveness model , 2009, The Lancet.

[38]  D. Bishai,et al.  Community‐based distribution of misoprostol for treatment or prevention of postpartum hemorrhage: Cost‐effectiveness, mortality, and morbidity reduction analysis , 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[39]  Suellen Miller,et al.  Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings. , 2004, Journal of midwifery & women's health.

[40]  S. Chopra,et al.  Severe anaemia in pregnancy: A tertiary hospital experience from northern India , 2010, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[41]  I. Bates,et al.  Maternal mortality in sub‐Saharan Africa: the contribution of ineffective blood transfusion services , 2008, BJOG : an international journal of obstetrics and gynaecology.

[42]  E. V. Beischer,et al.  OBSTETRICS AND THE NEWBORN , 1978, Archives of disease in childhood.

[43]  S. Sebayang,et al.  Programmatic Effects of a Large-Scale Multiple-Micronutrient Supplementation Trial in Indonesia: Using Community Facilitators as Intermediaries for Behavior Change , 2009, Food and nutrition bulletin.

[44]  N. Moss,et al.  Factors associated with acute postpartum hemorrhage in low‐risk women delivering in rural India , 2008, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[45]  G. Piaggio,et al.  WHO multicentre randomised trial of misoprostol in the management of the third stage of labour , 2001, The Lancet.

[46]  A. Baqui,et al.  Expanding uterotonic protection following childbirth through community‐based distribution of misoprostol: Operations research study in Nepal , 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[47]  D. Bishai,et al.  Cost‐effectiveness of misoprostol to control postpartum hemorrhage in low‐resource settings , 2007, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[48]  C. Stanton,et al.  Uterotonic use at home births in low‐income countries: A literature review , 2010, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[49]  Roger M Harbord,et al.  A modified test for small‐study effects in meta‐analyses of controlled trials with binary endpoints , 2006, Statistics in medicine.

[50]  Ndola Prata,et al.  Saving maternal lives in resource-poor settings: facing reality. , 2009, Health policy.

[51]  L. Morison,et al.  Misoprostol in the management of the third stage of labour in the home delivery setting in rural Gambia: a randomised controlled trial , 2005, BJOG : an international journal of obstetrics and gynaecology.

[52]  W. Holzgreve,et al.  Oral misoprostol for third stage of labor: a randomized placebo-controlled trial. , 1999, Obstetrics and gynecology.

[53]  M. Potts,et al.  Misoprostol use in the community to reduce maternal death – Authors' reply , 2010, The Lancet.

[54]  O. Pryds,et al.  Antenatal magnesium sulphate may prevent cerebral palsy in preterm infants—but are we convinced? Evaluation of an apparently conclusive meta‐analysis with trial sequential analysis , 2011, BJOG : an international journal of obstetrics and gynaecology.

[55]  G. Gyte,et al.  Active versus expectant management for women in the third stage of labour. , 2010, The Cochrane database of systematic reviews.

[56]  S. Khatry,et al.  Effects of prenatal micronutrient supplementation on complications of labor and delivery and puerperal morbidity in rural Nepal , 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[57]  P. Byass,et al.  Oral misoprostol for preventing postpartum haemorrhage in home births in rural Bangladesh: how effective is it? , 2011, Global health action.

[58]  M. Damodaram,et al.  Observer accuracy and reproducibility of visual estimation of blood loss in obstetrics: how accurate and consistent are health-care professionals? , 2010, Archives of Gynecology and Obstetrics.

[59]  J. Konje,et al.  Massive postpartum haemorrhage as a cause of maternal morbidity in a large tertiary hospital , 2004, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.